- Earth
Science Tech is a biotechnology company offering high-grade cannabinoids
- ETST
has diverse subsidiaries that promote the company’s role as a leader in
the CBD sector
- Earth
Science Tech has various partnerships and distribution agreements in place
Earth Science Tech Inc. (OTCQB: ETST) operates in the
hemp cannabinoid, nutraceutical, pharmaceutical and medical device research and
development fields. A biotechnology company headquartered in Doral, Florida,
ETST markets high purity and quality full-spectrum cannabinoids. The company’s
wholly owned subsidiaries – including Earth Science Pharmaceutical Inc.,
Cannabis Therapeutics Inc. and Canna Inno Laboratories Inc. – concentrate on
developing Earth Science Tech’s role as a worldwide leader in the CBD sector.
The company’s management team consists of experienced
industry experts from the nutraceuticals, dietary supplement and life sciences
fields. Earth Science Tech is developing new products and has secured several
partnerships, with strategic plans to extend its footprint within the medical
cannabis market. These partnerships will enable the company to develop new and
novel cannabinoid-based pharmaceutical and nutraceutical products (http://ibn.fm/P4T2M).
Wholly owned subsidiary Earth Science Pharmaceutical
develops low-cost, non-invasive diagnostic tools, medical devices, testing
processes and vaccines for sexually transmitted infections and diseases (STIs).
The executive team of Earth Science Pharma has years of scientific, medical and
business experience in the health, research and manufacturing fields. The
subsidiary is working to develop and bring to market medical devices and
vaccines that meet the specific needs of women.
Earth Science Pharma’s first medical device is MSN-2, a home
kit designed for the detection of STIs, such as chlamydia, from a self-obtained
gynecological specimen. Earth Science Tech is advancing clinical testing of
MSN-2 via a collaborative agreement with Laboratories BNK Canada (http://ibn.fm/Ckn54).
Wholly owned subsidiary Cannabis Therapeutics is working to
take a leadership role in the development of new, cutting-edge,
cannabinoid-based pharmaceutical and nutraceutical products. The company is
invested in research and development to explore and harness the medicinal power
of cannabidiol. Cannabis Therapeutics is also working to integrate the CBD
molecule with existing generic drug molecules. The company’s mission is to help
change the health care landscape by introducing its proprietary
cannabis/cannabinoid-based products made for the global pharmaceutical and
retail consumer markets.
Established in 2017, Canna Inno Laboratories is Earth
Science Tech’s Canadian subsidiary, based in Montreal, Québec. The company’s
mandate is to give ETST a foothold in Québec and provide the company with
access to government grants offered to innovators in the pharmaceutical
industry. One grant has been approved so far.
Earth Science Tech’s medical and industrial hemp products
are made from high-grade, full-spectrum cannabinoids that are extracted using
the supercritical CO2 liquid process. All of the company’s full-spectrum
cannabinoids are mixed in coconut MCT oil to ensure the best delivery and absorption,
and its offerings include CBD, CBDa, CBG, CBGa, CBN, CBC and CBDV; the
cannabinoids also contain terpenoids, aminos, omegas, saponins and flavonoids.
Earth Science Tech has entered into agreements with CannaBiz
and Desert Sun Distribution (http://ibn.fm/xknKJ)
for the distribution of the company’s high-grade, full-spectrum cannabinoids
line throughout pharmacies, chiropractors, dispensaries, athletic clubs and
clinics in the United States.
“We see tremendous synergy between our CBD line and the
health care practitioner and pharmacy spaces,” ETST Chief Sales Officer David
Barbash stated in a news release. “The distribution agreements with CannaBiz
and Desert Sun Distribution, while important, are only a fraction of the
opportunities we see for our CBD products.”
Earth Science Tech continues to develop its diverse
portfolio and pipeline. The company offers investors the opportunity to be part
of the burgeoning cannabinoid-based pharmaceutical and nutraceutical products
market as it expands its role as a leader in different sectors. Earth Science
Tech remains dedicated to developing leading-edge pharmaceutical and medical
device offerings.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates
relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
